167 related articles for article (PubMed ID: 36928087)
1. CRISPR/Cas9-mediated Cxcr4 disease allele inactivation for gene therapy in a mouse model of WHIM syndrome.
Gao JL; Owusu-Ansah A; Yang A; Yim E; McDermott DH; Jacobs P; Majumdar S; Choi U; Sweeney CL; Malech HL; Murphy PM
Blood; 2023 Jul; 142(1):23-32. PubMed ID: 36928087
[TBL] [Abstract][Full Text] [Related]
2. Low-level Cxcr4-haploinsufficient HSC engraftment is sufficient to correct leukopenia in WHIM syndrome mice.
Gao JL; Owusu-Ansah A; Paun A; Beacht K; Yim E; Siwicki M; Yang A; Liu Q; McDermott DH; Murphy PM
JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31687976
[TBL] [Abstract][Full Text] [Related]
3. Cxcr4-haploinsufficient bone marrow transplantation corrects leukopenia in an unconditioned WHIM syndrome model.
Gao JL; Yim E; Siwicki M; Yang A; Liu Q; Azani A; Owusu-Ansah A; McDermott DH; Murphy PM
J Clin Invest; 2018 Aug; 128(8):3312-3318. PubMed ID: 29715199
[TBL] [Abstract][Full Text] [Related]
4. Chromothriptic cure of WHIM syndrome.
McDermott DH; Gao JL; Liu Q; Siwicki M; Martens C; Jacobs P; Velez D; Yim E; Bryke CR; Hsu N; Dai Z; Marquesen MM; Stregevsky E; Kwatemaa N; Theobald N; Long Priel DA; Pittaluga S; Raffeld MA; Calvo KR; Maric I; Desmond R; Holmes KL; Kuhns DB; Balabanian K; Bachelerie F; Porcella SF; Malech HL; Murphy PM
Cell; 2015 Feb; 160(4):686-699. PubMed ID: 25662009
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Sustained Neutrophilia in Patient WHIM-09, Cured of WHIM Syndrome by Chromothripsis.
Liu Q; Li Z; Y Yang A; Gao JL; S Velez D; J Cho E; McDermott DH; Murphy PM
J Clin Immunol; 2018 Jan; 38(1):77-87. PubMed ID: 29177911
[TBL] [Abstract][Full Text] [Related]
6. WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.
Kawai T; Choi U; Cardwell L; DeRavin SS; Naumann N; Whiting-Theobald NL; Linton GF; Moon J; Murphy PM; Malech HL
Blood; 2007 Jan; 109(1):78-84. PubMed ID: 16946301
[TBL] [Abstract][Full Text] [Related]
7. CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
de Wit RH; Heukers R; Brink HJ; Arsova A; Maussang D; Cutolo P; Strubbe B; Vischer HF; Bachelerie F; Smit MJ
J Pharmacol Exp Ther; 2017 Oct; 363(1):35-44. PubMed ID: 28768817
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of stem cell engraftment on a WHIM.
Broxmeyer HE
J Clin Invest; 2018 Aug; 128(8):3240-3242. PubMed ID: 29939159
[TBL] [Abstract][Full Text] [Related]
9. WHIM syndrome: Immunopathogenesis, treatment and cure strategies.
McDermott DH; Murphy PM
Immunol Rev; 2019 Jan; 287(1):91-102. PubMed ID: 30565238
[TBL] [Abstract][Full Text] [Related]
10. Severe CD8+ T Lymphopenia in WHIM Syndrome Caused by Selective Sequestration in Primary Immune Organs.
Majumdar S; Pontejo SM; Jaiswal H; Gao JL; Salancy A; Stassenko E; Yamane H; McDermott DH; Balabanian K; Bachelerie F; Murphy PM
J Immunol; 2023 Jun; 210(12):1913-1924. PubMed ID: 37133343
[TBL] [Abstract][Full Text] [Related]
11. AMD3100 is a potent antagonist at CXCR4(R334X) , a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome.
McDermott DH; Lopez J; Deng F; Liu Q; Ojode T; Chen H; Ulrick J; Kwatemaa N; Kelly C; Anaya-O'Brien S; Garofalo M; Marquesen M; Hilligoss D; DeCastro R; Malech HL; Murphy PM
J Cell Mol Med; 2011 Oct; 15(10):2071-81. PubMed ID: 21070597
[TBL] [Abstract][Full Text] [Related]
12. WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.
Liu Q; Chen H; Ojode T; Gao X; Anaya-O'Brien S; Turner NA; Ulrick J; DeCastro R; Kelly C; Cardones AR; Gold SH; Hwang EI; Wechsler DS; Malech HL; Murphy PM; McDermott DH
Blood; 2012 Jul; 120(1):181-9. PubMed ID: 22596258
[TBL] [Abstract][Full Text] [Related]
13. WHIM Syndrome Caused by Waldenström's Macroglobulinemia-Associated Mutation CXCR4 (L329fs).
Liu Q; Pan C; Lopez L; Gao J; Velez D; Anaya-O'Brien S; Ulrick J; Littel P; Corns JS; Ellenburg DT; Malech HL; Murphy PM; McDermott DH
J Clin Immunol; 2016 May; 36(4):397-405. PubMed ID: 27059040
[TBL] [Abstract][Full Text] [Related]
14. Genetics on a WHIM.
Al Ustwani O; Kurzrock R; Wetzler M
Br J Haematol; 2014 Jan; 164(1):15-23. PubMed ID: 24111611
[TBL] [Abstract][Full Text] [Related]
15. The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.
Kallikourdis M; Trovato AE; Anselmi F; Sarukhan A; Roselli G; Tassone L; Badolato R; Viola A
Blood; 2013 Aug; 122(5):666-73. PubMed ID: 23794067
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency.
Heusinkveld LE; Yim E; Yang A; Azani AB; Liu Q; Gao JL; McDermott DH; Murphy PM
Expert Opin Orphan Drugs; 2017; 5(10):813-825. PubMed ID: 29057173
[TBL] [Abstract][Full Text] [Related]
17. Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.
Geier CB; Ellison M; Cruz R; Pawar S; Leiss-Piller A; Zmajkovicova K; McNulty SM; Yilmaz M; Evans MO; Gordon S; Ujhazi B; Wiest I; Abolhassani H; Aghamohammadi A; Barmettler S; Bhar S; Bondarenko A; Bolyard AA; Buchbinder D; Cada M; Cavieres M; Connelly JA; Dale DC; Deordieva E; Dorsey MJ; Drysdale SB; Ehl S; Elfeky R; Fioredda F; Firkin F; Förster-Waldl E; Geng B; Goda V; Gonzalez-Granado L; Grunebaum E; Grzesk E; Henrickson SE; Hilfanova A; Hiwatari M; Imai C; Ip W; Jyonouchi S; Kanegane H; Kawahara Y; Khojah AM; Kim VH; Kojić M; Kołtan S; Krivan G; Langguth D; Lau YL; Leung D; Miano M; Mersyanova I; Mousallem T; Muskat M; Naoum FA; Noronha SA; Ouederni M; Ozono S; Richmond GW; Sakovich I; Salzer U; Schuetz C; Seeborg FO; Sharapova SO; Sockel K; Volokha A; von Bonin M; Warnatz K; Wegehaupt O; Weinberg GA; Wong KJ; Worth A; Yu H; Zharankova Y; Zhao X; Devlin L; Badarau A; Csomos K; Keszei M; Pereira J; Taveras AG; Beaussant-Cohen SL; Ong MS; Shcherbina A; Walter JE
J Clin Immunol; 2022 Nov; 42(8):1748-1765. PubMed ID: 35947323
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Hematologic Effects of Endotoxin in Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome Model Mice.
Majumdar S; Gao JL; Pontejo SM; Balabanian K; Bachelerie F; Murphy PM
Immunohorizons; 2022 Jul; 6(7):543-558. PubMed ID: 35882421
[TBL] [Abstract][Full Text] [Related]
19. Chromothriptic cure of WHIM syndrome: Implications for bone marrow transplantation.
McDermott DH; Gao JL; Murphy PM
Rare Dis; 2015; 3(1):e1073430. PubMed ID: 26459672
[TBL] [Abstract][Full Text] [Related]
20. CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome.
Bachelerie F
Dis Markers; 2010; 29(3-4):189-98. PubMed ID: 21178277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
